Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Intro highlights steps to build credit with a secured card while avoiding debt, emphasizing payment discipline and utilization management.
22,404 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Berkshire Hathaway's Q1 2026 13F signals a policy shift under Greg Abel toward tech exposure, spotlighting Alphabet, ...
CoreWeave has turbocharged its AI compute backlog ahead of a Nasdaq-100 debut, placing the stock under fresh scrutiny...
Bitcoin anchors a high-stakes test as the STRC peg breaks and liquidity tightens. Microsoft issues a security advisor...
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Andre Cronje and two other Sonic Labs directors resign from the board, while the S token remains dramatically below i...
U.S. regulators propose bank-style rules for stablecoin issuers, demanding AML programs, data reporting, and reserve ...
Morningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
XRP sits near $1 as macro caution weighs on crypto. Analysts debate whether Ripple can spark a breakout in 2026, with...
The Senate approved a broad housing package in a bipartisan 85-5 vote, embedding a ban on issuing a CBDC through the ...
As AI workloads surge, memory demand is outpacing supply, potentially slowing the deployment of self-driving systems....
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...